BTAIVSPRME• 3 Months (Normalized)
BTAI vs PRME (BioXcel Therapeutics Inc. vs Prime Medicine Inc.)
Showing Closing Date Range from Jun, 19 to Sep, 17, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.07
+%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
PRME Performance $3.3
-2.12%
Prime Medicine Inc.
Normalized Baseline0.00%
Alpha Spread Margin BTAI LEADS
+2.12%
BTAI outperforming by 2.12%
BTAIPRME
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI PRME
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | BTAI Price | BTAI Gain (%) | PRME Price | PRME Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 17, 2026 | $- | $3.30 | -2.12% | - | |
| Sep 16, 2026 | $0.07 | -94.85% | $3.00 | -10.98% | -83.87% |
| Sep 15, 2026 | $0.04 | -96.56% | $3.14 | -6.82% | -89.74% |
| Sep 14, 2026 | $0.05 | -96.53% | $3.18 | -5.64% | -90.89% |
| Sep 11, 2026 | $0.05 | -96.08% | $3.13 | -7.12% | -88.96% |
| Sep 10, 2026 | $0.05 | -96.15% | $3.35 | -0.59% | -95.56% |
| Sep 09, 2026 | $0.05 | -96.38% | $3.47 | +2.97% | -99.35% |
| Sep 08, 2026 | $0.04 | -96.69% | $3.56 | +5.64% | -102.33% |
| Sep 04, 2026 | $0.07 | -94.32% | $3.70 | +9.79% | -104.11% |
| Sep 03, 2026 | $0.12 | -90.92% | $3.71 | +10.09% | -101.01% |
| Sep 02, 2026 | $0.11 | -91.77% | $3.67 | +8.90% | -100.67% |
| Sep 01, 2026 | $0.14 | -89.46% | $3.57 | +5.93% | -95.39% |
| Aug 31, 2026 | $0.16 | -87.46% | $3.59 | +6.53% | -93.99% |
| Aug 28, 2026 | $0.18 | -86.08% | $3.61 | +7.12% | -93.20% |
| Aug 27, 2026 | $0.72 | -44.69% | $3.64 | +8.01% | -52.70% |
Page 1 of 5